Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Omnicell (OMCL) PT Raised to $70 at Piper Jaffray
February 8, 2019 8:50 AM ESTPiper Jaffray analyst Sean Wieland raised the price target on Omnicell (NASDAQ: OMCL) to $70.00 (from $59.00) while maintaining a Neutral rating.
... MoreOmnicell (OMCL) Tops Q4 EPS by 3c, Revenues Miss; Offers Q1 & FY19 EPS Mid-Point Guidance Above Consensus, Q1 Revenues Guidance Below Consensus, FY19 Revenue Outlook Tops Views
February 7, 2019 4:36 PM ESTOmnicell (NASDAQ: OMCL) reported Q4 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $211.8 million versus the consensus estimate of $215.4 million.
"With the launch of our Autonomous Pharmacy vision at ASHP Midyear, health system pharmacists are... More
